LIDDS — Lidds AB Share News
0.000.00%
- SEK3.36m
- SEK1.62m
Brief: Lidds Says Has Cash Runway Expected To Extend Into 2025
Brief: Lidds Appoints Jenni Björnulfson As New CEO
Brief: Lidds Q3 EBIT Loss SEK 4.5 Million
Brief: Lidds Appoints Matthew Lindon As Acting CEO
Brief: Lidds Announces Cost Containment Measures
Brief: Lidds Q1 EPS at SEK -0.18
Brief: Lidds Posts Q4 Net Income of SEK -9.1 Million
Brief: Lidds Q4 Operating Loss SEK 8.9 Mln
Brief: LIDDS Announces Final Outcome In Rights Issue
Brief: LIDDS Raises About SEK 46.5 Mln Through Rights Issue
Brief: LIDDS Signs Deal With Alira Health
Brief: LIDDS BoD Decides On Rights Issue Of About SEK 48.6 Mln
Brief: Lidds Q3 Operating Loss Widens To SEK 8.1 Mln
Brief: Lidds Q2 Operating Loss At SEK 9.9 Mln
Brief: Lidds Appoints Anders Månsson As CEO
Brief: Lidds Patent Covering NanoZolid Production Process Granted In Israel
Brief: Lidds Granted Patent For Nanozolid Production Process In Japan, South Korea
Brief: Lidds Jan-March Oper Loss Narrows To SEK 9.8 Mln
Brief: LIDDS Oct-Dec Oper Loss Narrows To SEK 8.9 Mln